Nicole Sweeny
Chief Commercial Officer, Praxis Precision Medicines, Inc.
Companies
- Monopar TherapeuticsBoard member Jun 30, 2026 to now1
- KalVista Pharmaceuticals, Inc.Chief Commercial Officer Aug 25, 2025 to now2
- Praxis Precision Medicines, Inc.Chief Commercial Officer Oct 15, 2020 to Feb 13, 20233
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Praxis Precision Medicines, Inc. PRAX38,619 shares4$9.6M at $248.24Feb 12, 2023
- KalVista Pharmaceuticals, Inc.0 shares5Jun 11, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 11, 2026Returned to company 59,291 shares of KalVista Pharmaceuticals, Inc.5
- May 26, 2026Sold 1,489 shares at $26.78 of KalVista Pharmaceuticals, Inc.6
- May 22, 2026Sold 1,861 shares at $26.78 of KalVista Pharmaceuticals, Inc.7
- May 22, 2026Exercised options 5,000 shares of KalVista Pharmaceuticals, Inc.6
- May 21, 2026Exercised options 6,250 shares of KalVista Pharmaceuticals, Inc.7
- Apr 17, 2026Sold 1,862 shares at $20.22 of KalVista Pharmaceuticals, Inc.8
- Apr 16, 2026Exercised options 6,250 shares of KalVista Pharmaceuticals, Inc.8
- Feb 23, 2026Sold 3,975 shares at $15.57 of KalVista Pharmaceuticals, Inc.9
- Feb 22, 2026Exercised options 5,000 shares of KalVista Pharmaceuticals, Inc.9
- Feb 21, 2026Exercised options 6,250 shares of KalVista Pharmaceuticals, Inc.9
- Nov 24, 2025Sold 3,813 shares at $13.45 of KalVista Pharmaceuticals, Inc.10
- Nov 22, 2025Exercised options 5,000 shares of KalVista Pharmaceuticals, Inc.10
- Nov 21, 2025Exercised options 6,250 shares of KalVista Pharmaceuticals, Inc.10
- Aug 25, 2025Sold 1,480 shares at $13.42 of KalVista Pharmaceuticals, Inc.11
- Aug 22, 2025Sold 1,864 shares at $13.22 of KalVista Pharmaceuticals, Inc.12
- Aug 22, 2025Exercised options 5,000 shares of KalVista Pharmaceuticals, Inc.11
- Aug 21, 2025Exercised options 6,250 shares of KalVista Pharmaceuticals, Inc.12
- Feb 12, 2023Shares withheld for tax 1,456 shares at $3.94 of Praxis Precision Medicines, Inc.4
- Jan 7, 2023Shares withheld for tax 2,079 shares at $2.52 of Praxis Precision Medicines, Inc.13
- May 13, 2022Granted 2,587 shares at $8.80 of Praxis Precision Medicines, Inc.14
- Feb 12, 2022Shares withheld for tax 1,233 shares at $12.85 of Praxis Precision Medicines, Inc.15
- Jan 7, 2022Granted 24,000 shares of Praxis Precision Medicines, Inc.16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARMonopar Therapeutics, Board member
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed May 27, 2026
- 7SEC EDGARForm 4 filed May 26, 2026
- 8SEC EDGARForm 4 filed Apr 20, 2026
- 9SEC EDGARForm 4 filed Feb 24, 2026
- 10SEC EDGARForm 4 filed Dec 4, 2025
- 11SEC EDGARForm 4 filed Aug 26, 2025
- 12SEC EDGARForm 4 filed Aug 25, 2025
- 13SEC EDGARForm 4 filed Jan 9, 2023
- 14SEC EDGARForm 4 filed May 18, 2022
- 15SEC EDGARForm 4 filed Feb 15, 2022
- 16SEC EDGARForm 4 filed Jan 11, 2022